252
Participants
Start Date
December 21, 2023
Primary Completion Date
January 31, 2025
Study Completion Date
July 31, 2026
BCD-264
IV, 16 mg/kg
Darzalex
IV, 16 mg/kg
RECRUITING
Chelyabinsk Regional Clinical Hospital, Chelyabinsk
RECRUITING
Kuzbass Regional Clinical Hospital named after S.V. Belyaev, Kemerovo
RECRUITING
Regional Clinical Hospital, Krasnoyarsk
RECRUITING
Moscow City Clinical Hospital 52, Moscow
RECRUITING
S.P. Botkin Moscow City Clinical Hospital, Moscow
RECRUITING
Almazov National Medical Research Centre, Saint Petersburg
RECRUITING
N.N. Petrov National Medicine Research Center of oncology, Saint Petersburg
RECRUITING
Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency, Saint Petersburg
RECRUITING
St Petersburg State I.P. Pavlov Medical University, Saint Petersburg
RECRUITING
State budgetary healthcare institution Leningrad Regional Clinical Hospital, Saint Petersburg
RECRUITING
Samara State Medical University, Samara
RECRUITING
Oncological dispensary No. 2 of the Ministry of Health of the Krasnodar Territory, Sochi
RECRUITING
Bashkir State Medical University, Ufa
RECRUITING
Sverdlovsk Regional Clinical Hospital No. 1, Yekaterinburg
Lead Sponsor
Biocad
INDUSTRY